Related Experiment Video
Updated: Jun 2, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Splice site mutations in the ATP7A gene
Tina Skjørringe1, Zeynep Tümer, Lisbeth Birk Møller
1Department of Applied Functional Human Genetics, The Kennedy Center, Glostrup, Denmark.
Abstract:
Menkes disease (MD) is caused by mutations in the ATP7A gene. We describe 33 novel splice site mutations detected in patients with MD or the milder phenotypic form, Occipital Horn Syndrome. We review these 33 mutations together with 28 previously published splice site mutations. We investigate 12 mutations for their effect on the mRNA transcript in vivo. Transcriptional data from another 16 mutations were collected from the literature. The theoretical consequences of splice site mutations, predicted with the bioinformatics tool Human Splice Finder, were investigated and evaluated in relation to in vivo results. Ninety-six percent of the mutations identified in 45 patients with classical MD were predicted to have a significant effect on splicing, which concurs with the absence of any detectable wild-type transcript in all 19 patients investigated in vivo. Sixty-seven percent of the mutations identified in 12 patients with milder phenotypes were predicted to have no significant effect on splicing, which concurs with the presence of wild-type transcript in 7 out of 9 patients investigated in vivo. Both the in silico predictions and the in vivo results support the hypothesis previously suggested by us and others, that the presence of some wild-type transcript is correlated to a milder phenotype.
Insights
Menkes disease (MD) and Occipital Horn Syndrome are linked to ATP7A gene mutations. Novel splice site mutations were identified, with in silico predictions correlating with in vivo results regarding disease severity.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Menkes disease (MD) and Occipital Horn Syndrome (OHS) are rare genetic disorders.
- These conditions result from mutations in the ATP7A gene, affecting copper transport.
- Splice site mutations are a significant cause of these allelic disorders.
Purpose of the Study:
- To identify and characterize novel splice site mutations in the ATP7A gene.
- To investigate the in vivo effects of these mutations on mRNA transcripts.
- To correlate in silico predictions of splicing effects with observed clinical phenotypes.
Main Methods:
- Mutation screening in patients with MD and OHS.
- In silico analysis using the Human Splice Finder tool.
- In vivo analysis of mRNA transcripts from patient samples.
Main Results:
- 33 novel splice site mutations were identified in ATP7A.
- In silico predictions accurately reflected in vivo splicing defects for most mutations.
- Classical MD patients predominantly showed significant splicing effects and absence of wild-type transcript.
- Milder phenotypes (OHS) often had mutations with no significant predicted splicing effect and retained wild-type transcript.
Conclusions:
- The presence of wild-type ATP7A transcript correlates with milder phenotypes in MD and OHS.
- In silico tools like Human Splice Finder are valuable for predicting the functional impact of splice site mutations.
- Understanding genotype-phenotype correlations aids in diagnosing and managing Menkes disease and Occipital Horn Syndrome.
Related Concept Videos
ATP Synthase: Mechanism
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Point and Frameshift Mutations
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
